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Abstract
Background: There is no physiotherapy-specific quality indicator tool available to evaluate physiotherapy care for
people with hip and/or knee osteoarthritis (OA). This study aimed to develop a patient-reported quality indicator
tool (QUIPA) for physiotherapy management of hip and knee OA and to assess its reliability and validity.
Methods: To develop the QUIPA tool, quality indicators were initially developed based on clinical guideline
recommendations most relevant to physiotherapy practice and those of an existing generic OA quality indicator
tool. Draft items were then further refined using patient focus groups. Test-retest reliability, construct validity
(hypothesis testing) and criterion validity were then evaluated. Sixty-five people with hip and/or knee OA attended
a single physiotherapy consultation and completed the QUIPA tool one, twelve- and thirteen-weeks after.
Physiotherapists (n = 9) completed the tool post-consultation. Patient test-retest reliability was assessed between
weeks twelve and thirteen. Construct validity was assessed with three predefined hypotheses and criterion validity
was based on agreement between physiotherapists and participants at week one.
Results: A draft list of 23 clinical guideline recommendations most relevant to physiotherapy was developed.
Following feedback from three patient focus groups, the final QUIPA tool contained 18 items (three subscales)
expressed in lay language. The test-retest reliability estimates (Cohen’s Kappa) for single items ranged from 0.30–
0.83 with observed agreement of 64–94%. The intraclass correlation coefficient (ICC) and 95% confidence interval
(CI) for the Assessment and Management Planning subscale was 0.70 (0.54, 0.81), Core Recommended Treatments
subscale was 0.84 (0.75, 0.90), Adjunctive Treatments subscale was 0.70 (0.39, 0.87) and for the total QUIPA score
was 0.80 (0.69, 0.88). All predefined hypotheses regarding construct validity were confirmed. However, agreement
between physiotherapists and participants for single items showed large measurement error (Cohen’s Kappa
estimates ranged from − 0.04-0.59) with the ICC (95% CI) for the total score being 0.11 (− 0.14, 0.34).
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Conclusions: The QUIPA tool showed acceptable test-retest reliability for subscales and total score but inadequate
reliability for individual items. Construct validity was confirmed but criterion validity for individual items, subscales
and the total score was inadequate. Further research is needed to refine the QUIPA tool to improve its clinimetric
properties before implementation.
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Background
Osteoarthritis (OA) is a leading cause of joint pain
and disability worldwide [1] with the overall preva-
lence of hip and knee OA in the adult population ap-
proximately 11 and 24% respectively [2].
Osteoarthritis costs Australia’s economy $22 billion
annually, and the burden of OA is expected to rise
due to the ageing population and obesity [3, 4]. Phys-
iotherapists play an integral role in providing non-
pharmacological management for OA. A systematic
review of patients’ perceived health service needs for
OA showed that patients generally perceive physio-
therapists to be important to assist them in managing
their condition and prescribing exercises [5].
Despite international OA guidelines recommending
exercise and weight loss [1, 6, 7] as first line treat-
ments for OA, their uptake is suboptimal in physio-
therapy practice [8–11]. Quality indicators (QIs) can
be used to assess physiotherapists’ adherence to clin-
ical guidelines recommendations and are accepted
tools for assessing OA care [12–14]. They represent
minimal acceptable standards of practice [15, 16] and
are typically developed via consensus techniques [17,
18]. Quality indicators can be assessed by auditing
medical records [18] however, these do not always in-
clude information pertaining to quality of care. Self-
reporting by health professionals is another method
but may introduce bias. To overcome limitations of
these methods, patient-reported QIs are an alternative
option to assess quality of OA care. Patient involve-
ment in quality assessment is also valuable to en-
hance quality and relevance of research [19] as well
as to promote patient-centred care, one of the six pil-
lars of high quality care [20].
A systematic review conducted in 2013 identified QIs
from 32 papers pertaining to non-pharmacological,
pharmacological and surgical management for OA [13]
but found only one study [21] (from Norway) that devel-
oped QIs in a patient-reported format. Blackburn and
colleagues [22] later developed a similar QI question-
naire in the United Kingdom (UK) by including items
from the Norwegian questionnaire. The UK-QI ques-
tionnaire was subsequently used by patients across sev-
eral European countries to assess the care they received
from a range of health professionals for their OA man-
agement [23, 24]. However, the UK questionnaire was
not tailored to specifically evaluate physiotherapy care.
In the Netherlands in 2016, a set of QIs for physiother-
apy management in hip and knee OA was established
using a Delphi technique [25] but was not developed
into a patient-reported tool. Furthermore, the QIs were
based on older clinical guidelines from 2011 [26] and
were not developed with an international perspective
given they only recruited a national group of experts for
their Delphi panel.
Given the lack of specific patient-reported QIs to
assess physiotherapy care for hip and/or knee OA,
this study aimed to develop a patient-reported QI
tool and to evaluate its clinimetric properties. It is
vital to establish the validity and reliability of QI tools
if the results are to accurately reflect physiotherapy
practice and/or be used to guide decision-making to
improve clinical services [27]. These measurement cri-
teria are prerequisite for any quality measure and
should be established prior to implementation of the
QIs [16, 18].
Methods
Phase 1: tool development
We used two sequential stages to develop the Quality
Indicators for Physiotherapy Management of Hip and
Knee Osteoarthritis (QUIPA) tool: 1) drafting of patient-
reported QIs based on clinical guideline recommenda-
tions most relevant to physiotherapy practice identified
from a recent consensus study [28] and the UK-QI ques-
tionnaire [22] and 2) refinement of the language and for-
mat of the QUIPA tool to ensure it was consumer
friendly.
The research members involved in this study in-
cluded physiotherapists who are also experts in OA
research (KB, RH, TE, KD) and QI development and
implementation (KD). KD has extensive experience in
QI development and use for implementation of Na-
tional Institute for Health and Care Excellence Qual-
ity Standards through clinical tools and patient
questionnaires. KD was involved in the UK-QI study
[13] which included patient and public involvement
and engagement, as experts by experience.
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Stage 1 – drafting of patient-reported quality indicators
for physiotherapy care
Draft QIs were derived from a final list of clinical guide-
line recommendations for hip and/or knee OA proposed
by a recent consensus study as being most relevant to
physiotherapy care [28]. The study first extracted recom-
mendations from two high-quality clinical guidelines [1,
29] and then included a panel of 62 international physio-
therapists to complete an online modified-Delphi survey,
followed by a priority-ranking exercise in order to iden-
tify and rank recommendations most relevant for
physiotherapy practice. The final 30 recommendations
were then synthesized and grouped by content area to
convey a physiotherapy management for hip and/or knee
OA. A conceptual model based on the results of the
study [28] was used when developing the QUIPA tool.
The four main content areas of the final recommenda-
tions were condensed to form the three subscales of the
QUIPA tool. We aimed to develop a QI relevant to each
of the 30 recommendations on the final list, whilst mini-
mising redundancy across items. Thus, where recom-
mendations were similar, we only developed a QI based
on the highest ranked recommendation [28]. We did not
develop a QI for recommendations if it was deemed by
the research experts as difficult to assess in a physiother-
apy consultation; captured in another individual QI; re-
lated to a health service program instead of an individual
treatment or unable to be executed by a physiotherapist
(e.g. referring patients for joint surgery). Where the rec-
ommendations overlapped with those in the UK-QI
questionnaire [22], we utilised similar phrasing as the
UK-QI questionnaire because it had been through a
rigorous development process, involved patient partici-
pation and was based on the most recent QIs, both from
the Norwegian patient-reported QI questionnaire [21]
and the systematic review in 2013 [13]. Although the
Norwegian team has since revised and validated their QI
questionnaire [30], it contains similar QIs to that of the
previous version. The first draft of the QUIPA tool is at-
tached in Additional file 1.
Stage 2 – refinement of the language and format of the
QUIPA tool
Patient and public involvement
A convenience sample of 15 people with hip and/or knee
OA living in Melbourne, Australia were recruited from
our research database and via Facebook to participate in
one of three face-to-face focus groups to further refine
the QUIPA tool. Inclusion criteria were: i) aged 45 years
or above, ii) being told they had OA in their hip and/or
knee by a health professional, iii) saw a physiotherapist
for their hip and/or knee OA over the last 3 months,
and iv) able to attend the University for allocated session
date/time. Ethical approval was granted by the School of
Health Sciences Human Ethics Advisory Group, Univer-
sity of Melbourne (Ethics Application 1,750,532).
Each focus group session ran for 90 min and was mod-
erated by a research team member and an assistant. Ses-
sions were audio-recorded. Participants firstly completed
a questionnaire about demographics as well as hip/knee
pain and function. They were then presented with the
draft QUIPA tool and asked to explain what they under-
stood each QI item meant to ensure consistency with its
original intent, a technique known as cognitive debrief-
ing [31]. They were also asked to comment on wording
clarity. The QUIPA tool was projected onto a presenta-
tion screen to allow the research assistant to alter the
wording of the QIs in real time during the group session.
Participants were also asked to comment on the appro-
priateness of the tool response scale and its overall for-
mat and layout [22, 32]. The research team revised and
reworded the QUIPA tool following each focus group
session before presenting the revised version to the sub-
sequent group. Additional file 10 represents the final
version of the QUIPA tool.
Phase 2: Clinimetric evaluation of the QUIPA tool
The evaluation study was performed between August
and December 2018. Participants with hip and/or knee
OA were recruited to attend a single one-on-one con-
sultation with a designated study physiotherapist for as-
sessment and treatment of their affected joint(s). They
were then required to complete the QUIPA tool online
at three time points: one week (W1), twelve weeks
(W12) and thirteen weeks (W13) after their consultation.
A three-month recall period was selected for the QUIPA
tool to capture either single or multi-session episodes of
physiotherapy care and has been utilised in other com-
parable tools [22, 23]. For the purpose of this study, par-
ticipants were asked not to have any further
physiotherapy consultations for their affected hip and/or
knee joint(s) during the thirteen weeks to avoid treat-
ment confusion. For the purpose of this clinimetric
evaluation, we also established a physiotherapist version
of the QUIPA tool, which contained the same items but
worded from the physiotherapists’ perspective. Physio-
therapists completed the tool immediately post-
consultation (W0). Ethical approval was granted by the
School of Health Sciences Human Ethics Advisory
Group, University of Melbourne (Ethics Application 1,
750,925).
To evaluate patient test-retest reliability, we examined
the participant responses between W12 and W13. We
used three a priori hypotheses to assess construct valid-
ity. The hypotheses reflected anticipated response pat-
terns among contrasting subgroups in relation to body
mass index (BMI), pain level with walking and daily
functional ability [21]. Criterion validity was determined
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by assessing agreement between physiotherapists and
participants at W1. We defined responses from the
physiotherapists as ‘gold standard’ as we expected their
responses to be the most accurate compared to the par-
ticipants since they completed the tool immediately after
the consultation session and knew what treatment they
had administered.
Study participants
A convenience sample of adults aged 45 years or over
with self-reported hip and/or knee OA were recruited
from the CHESM research database and by advertise-
ments on Facebook. We aimed for a minimum of 50
people to participate in the clinimetric study because
this sample size is the minimum recommended for any
health questionnaire validity and/or reliability study [33].
The proposed minimum sample size allowed for a broad
cross-sectional representation of people with hip and/or
knee OA, including ages, genders and OA severity.
Participants were required to meet the National Insti-
tute for Health and Care Excellence OA clinical criteria:
i) aged 45 years or above ii) have activity-related hip
and/or knee pain and 3) have no more than 30min of
morning stiffness in their hip and/or knee. Participants
were excluded if they had inflammatory arthritis, had
undergone hip/knee replacement surgery for the affected
hip/knee(s), planned to see another physiotherapist
within thirteen weeks and/or were unable to give con-
sent, attend an appointment with one of the study phys-
iotherapists or to complete the questionnaires online at
the specified time points.
We recruited nine physiotherapists currently registered
to practise in Australia and working in private practice
settings within Melbourne to ensure geographical spread
around Melbourne for participants’ convenience.
Procedure
Participants received one consultation from their desig-
nated study physiotherapist at no cost to themselves. In
order to increase variability in the care provided within a
standard 30-min consultation, physiotherapists were
provided with different cue cards that contained specific
tasks/treatments they were requested to do, or not do,
with the participants. Participants were informed that
the physiotherapists were going to provide a range of
different treatments to different participants, and thus
individual participants did not have any pre-conceived
ideas about what they would or would not receive. Par-
ticipants were emailed a link to the online QUIPA tool
at one, twelve and thirteen weeks following their physio-
therapy session and were asked to complete the tool as
soon as they could. With the W1 QUIPA tool, partici-
pants were also asked to provide information about
demographic, other medical conditions, height and
weight as well as to complete the pain and function sub-
scales of the Western Ontario and McMaster Univer-
sities Osteoarthritis Index (WOMAC). Participants were
asked whether they had seen another physiotherapist
each time they completed the QUIPA tool. Reminder
emails and text messages were sent to non-responders
daily (up to three times) after responses were due. To
maximise completion of surveys [34], those who com-
pleted all three were entered into a draw to win a $100
gift card.
Physiotherapists were asked to complete the QUIPA
tool online immediately following each consultation.
Physiotherapists were reimbursed $60 for each partici-
pant they saw.
Statistical analysis
Reliability
Test-retest reliability of the QUIPA tool for participants
was determined by comparing their responses between
W12 (+/− 7 days) and W13 (− 2 /+ 7 days). Test-retest
reliability for individual QI items was assessed by calcu-
lating Cohen’s Kappa (95% confidence intervals CI), per-
centage of observed agreement (i.e. the percentage of
occasions when the answer was identical between W12
and W13), and percentage of expected agreement (i.e.
the percentage of occasions when the answer was ex-
pected by chance to be identical between W12 and
W13). Cohen’s Kappa compares the expected agreement
to that observed. Kappa values were interpreted accord-
ing to Landis and Koch [35]: 0–0.20 slight; 0.21–0.40
fair; 0.41–0.60 moderate; 0.61–0.80 substantial and
0.81–1.00 almost perfect reliability.
Test-retest for each QUIPA subscale and the total
score was assessed with intraclass correlation coefficients
(ICC) (95% CI) estimated using a two-way mixed effect
model. An ICC of ≥0.70 was considered acceptable [33].
Validity
Construct validity was assessed with three predefined
hypotheses. We first hypothesized that people respond-
ing ‘not overweight’ for the QI on benefits of losing
weight (item #13a) would self-report lower BMI com-
pared to those responding ‘yes’, ‘no’ or ‘don’t remember’.
We also hypothesized that people responding ‘no such
problems’ for the QIs on the walking aid item (#14) and
the appliances and aids item (#15) would report no diffi-
culty with walking and score lower for total physical
function score on the WOMAC respectively compared
to those responding ‘yes’, ‘no’ or ‘don’t remember’. Chi-
square tests were used to test the first and second hy-
potheses and a t-test was used for the third hypothesis.
The p-value cut off for statistical significance was ≤0.05
for both statistical tests. Validity was considered
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acceptable if ≥75% of the predefined hypotheses were
confirmed [33].
Criterion validity of the QUIPA tool was deter-
mined by assessing agreement between physiothera-
pists and participants at W1 on individual items, each
subscale and the total score of the QUIPA tool. To
assess agreement for individual QI items, Cohen’s
Kappa (95% CI), the percentage of observed agree-
ment and percentage of expected agreement between
physiotherapists and patients were calculated. Agree-
ment for each subscale and the total score was
assessed with an ICC (95% CI) estimated using a
two-way mixed effect model.
Pass rates for individual QIs
The pass rate (%) for each QI was calculated based on
responses from physiotherapists and patients at Week 1,
where the numerator represented the total of ‘yes’ an-
swers for the QI and the denominator was the total of
‘yes’ and ‘no’ answers for the QI. The denominator did
not include other response options as they were deemed
not relevant to a calculation of pass rate.
Results
Phase 1: tool development
Stage 1 – drafting of patient-reported quality indicators for
physiotherapy care
Thirty recommendations were extracted from the con-
sensus study that identified the clinical guideline recom-
mendations most relevant to physiotherapy practice [28].
Of these, QIs were not developed for 11 recommenda-
tions and six recommendations were partly excluded
(Additional file 2). The remaining 19 recommendations
(Additional file 1) were converted into QIs, utilizing the
phrasings from the UK-QI questionnaire [22] where pos-
sible. Of these 19, four recommendations were con-
verted into two QIs each whilst only one QI was
generated from each of the remaining 15 recommenda-
tions. Thus in total, 23 QIs formed the first draft of the
QUIPA tool. Each QI was assigned with either a three or
four-level response scale (i.e. ‘yes’/ ‘no’/ ‘don’t remember’
or ‘yes’/ ‘no’/ ‘don’t remember’/ ‘no such problems’ or
‘not overweight’ or ‘already doing own exercise pro-
gram’) (Additional file 1).
Stage 2 – refinement of the language and format of the
QUIPA tool
Patient and public involvement
The first focus group was conducted with seven partici-
pants and the other two groups with four each. The
mean (standard deviation) age of the participants was
63.9 (9.1) years and all had either knee OA or hip and
knee OA. Participants’ characteristics are provided in
Additional file 3.
Focus group feedback
Following feedback from the focus groups, several
changes were made to the draft QUIPA tool (Additional
file 1). This included reducing the number of items on
the tool to ease participant burden (Q6-8a, Q17), remov-
ing items that were perceived to be too vague to partici-
pants (Q5 & 19), reducing words to improve clarity (Q1,
4, 8a, 8b, 8c, 9a, 9b, 16 and 18), avoiding multiple di-
mensions of care within a single item by splitting the QI
into two questions (Q3) and expanding some QIs to im-
prove specificity (Q2, 14). One item (Q20) was removed
due to conflicting evidence supporting its effectiveness
that emerged during the course of the study. Participants
felt that the three-month recall period was appropriate
and were satisfied with the response options and format
of the tool.
Final QUIPA tool
The final version of the QUIPA tool comprised 18 items
(Additional file 10: Table S1 and Additional file 1), orga-
nised into three subscales (Additional file 10: Table S1).
The first subscale was Assessment and Management
Planning and comprised the six items concerning OA
assessment, comorbidities, screening for depression,
depression referral, management planning and review.
The second subscale was Core Recommended Treat-
ments and contained the eight items concerning OA
and related pain, education about different treatment
options for OA, specific exercise program prescrip-
tion, exercise preferences, exercise adherence, educa-
tion about benefits of weight loss and strategies for
losing weight. In this subscale, if ‘no’ was ticked for
the item relating to specific exercise program pre-
scription (item #10), then the item concerning exer-
cise adherence (item #12) was automatically omitted
by the scorer as not applicable. In addition, if an an-
swer other than ‘yes’ was ticked for the item relating
to benefits of weight loss (item #13a), the item ad-
dressing strategies for losing weight (item #13b) was
also omitted as not applicable. The final subscale was
Adjunctive Treatments and consisted of the four
items relating to walking aids, appliances and aids,
work-related advice and footwear.
Scoring instructions for the QUIPA tool
Table 1 represents the scoring instructions for the
QUIPA tool. The pass rate (%) for each subscale was
calculated independently, where the numerator repre-
sented the total of ‘yes’ ticked in the subscale and the
denominator was the total of ‘yes’ and ‘no’ ticked in
the subscale. For each subscale, if more than 50% of
the items were not responded with ‘yes’ or ‘no’ an-
swers, the response was considered invalid and the
subscale score was not calculated. The total pass rate
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(%) of the QUIPA tool was calculated from all re-
sponses, where the numerator represented the total of
‘yes’ ticked on the tool, and the denominator was the
total of ‘yes’ and ‘no’ ticked before the total score was
normalized to 100. Percentage of score ranged from 0
to 100, with 100% representing the highest quality of
care score.
Phase 2: evaluation of the QUIPA tool
Characteristics of participants
Of 90 eligible participants, 65 (72%) attended a
physiotherapy consultation session. More than half
were female (63%) and the mean (standard deviation)
age was 64.5 (8.1) years. The majority of the partici-
pants (80%) had only knee OA, 15% had hip and
knee OA, and 5% had only hip OA (Additional
file 4).
Characteristics of physiotherapists
Of the 16 physiotherapists who expressed interest in the
project, nine (four female) were selected based on clin-
ical practice locations. More than half of the physiother-
apists had ≤10 years of clinical experience, worked
clinically ≥31 h weekly and saw ≥10 patients with hip
and/or knee OA monthly (Additional file 5).
Test-retest reliability
Of the 65 participants who attended physiotherapy con-
sultations, 63 (97%) completed the QUIPA tool within
the specified timeframes for W12 and W13. The Kappa
coefficients for individual QI items ranged from 0.30–
0.83, with one demonstrating ‘almost perfect’ agreement,
one ‘substantial’, thirteen ‘moderate’ and three ‘fair’
agreement [35] (Table 2). The percentage of observed
agreement ranged from 64 to 94% and expected agree-
ment ranged from 30 to 64%. Of the 63 participants, 23
reported being ‘not overweight’. More than a third of the
total participants selected ‘no such problems’ for QIs
targeting OA subgroups i.e. item #14 walking aid (n =
23), item #15 appliances and aids (n = 32), item #16
work advice (n = 43) and item #3 depression screening
(n = 38) at W12. The ICC (95% CI) for the Assessment
and Management Planning subscale (n = 58) was 0.70
(0.54, 0.81), Core Recommended Treatments subscale
(n = 56) was 0.84 (0.75, 0.90) and Adjunctive Treatments
subscale (n = 20) was 0.70 (0.39, 0.87). The ICC (95% CI)
for the total score (n = 63) was 0.80 (0.69, 0.88).
Validity
Construct Construct validity was considered acceptable
with all three pre-defined hypotheses confirmed (Add-
itional file 6).
Agreement between treating physiotherapists and
participants at W1 - The Kappa coefficients for individ-
ual QIs ranged from − 0.04-0.59, with two demonstrat-
ing ‘moderate’, eight demonstrating ‘fair’ and six
demonstrating ‘slight’ agreement [35]. The Kappa coeffi-
cients for two QIs were below 0 (Table 3). The percent-
age of observed agreement ranged from 46 to 86% and
for expected agreement from 32 to 75%. The ICC (95%
CI) for the Assessment and Management Planning sub-
scale (n = 63) was 0.20 (− 0.05, 0.43), Core Recom-
mended Treatments subscale (n = 65) was 0.06 (− 0.19,
0.29) and Adjunctive Treatments subscale (n = 21) was
0.70 (0.39, 0.87). The ICC (95% CI) for the total score
(n = 65) was 0.11 (− 0.14, 0.34).
Pass rates for individual QIs Additional file 7and 8
show the pass rates for individual QIs as reported by
physiotherapists and patients at Week 1 respectively.
Table 1 Scoring instructions for the Quality Indicators for
Physiotherapy Management of Hip and Knee Osteoarthritis
(QUIPA)
Objective
The QUIPA tool is a patient-reported questionnaire used to assess
patient perspectives on whether physiotherapists are providing
evidence-based care when managing hip and/or knee osteoarthritis.
It is a self-administered questionnaire consisting of 18 items divided
into 3 subscales:
• Assessment and management planning: Q1–6
• Core recommended treatments: Q7-13b
• Adjunctive treatments: 14–17
The last 12 weeks is the time period considered when answering the
questions.
Method of use
The QUIPA tool takes approximately 15 min to complete. For each
question, tick ONLY 1 box corresponding to your response.
For question 10, if the answer was ‘no’, question 12 should be
omitted and not answered.
For question 13a, if the answer was ‘no’, ‘don’t remember’ or ‘not
overweight’, question 13b should be omitted and not answered.
Scoring instructions
Each subscale score is calculated independently as below. Do not
score if there is a missing response or if the response is in the grey
columns.
For each subscale, if > 50% of the subscale items have not been
responded with ‘yes’ or ‘no’ answers, the response is considered
invalid and no subscale score should be calculated. For subscale
Assessment and management planning, this means that 3 items must
be answered; for Core recommended treatments, 4 items; and for
Adjunctive treatments, 2 items must be answered in order to
calculate a subscale score.
Score (S) for each subscale:
S ¼ Total of‘yes’Total of‘yes’&‘no’X 100%
For the total score of the QUIPA tool, add up the responses from all 3
subscales as below.
Total Score (ToS):
ToS ¼ Total of‘yes’from all 3 subscalesTotal of‘yes’&‘no’from all 3 subscales X 100%
Interpreting the results
The QUIPA tool is used to measure quality indicator pass rates for
physiotherapists in managing hip/knee osteoarthritis. Percentage
score is calculated, ranging from 0 to 100, with 100% representing
the best quality of care score.
Teo et al. BMC Musculoskeletal Disorders          (2020) 21:202 Page 6 of 11
Table 2 Patient test-retest reliability for individual quality indicator at Week 12 and 13 (n = 63)
Quality Indicators a Cohen’s Kappa 95% CI Observed agreement (%) Expected agreement (%)
1. Osteoarthritis assessment 0.38 0.11, 0.62 77.8 64.3
2. Comorbidities 0.48 0.30, 0.65 68.3 38.6
3. Depression screening 0.48 0.27, 0.65 68.3 39.5
4. Depression referral 0.49 0.29, 0.70 76.2 53.3
5. Management plan 0.33 0.10, 0.53 66.7 50.2
6. Physiotherapy review 0.46 0.27, 0.63 71.4 47.3
7. Osteoarthritis definition 0.57 0.38, 0.74 74.6 41.6
8. Osteoarthritis pain 0.54 0.32, 0.72 76.2 48.7
9. Treatment risk and benefits 0.53 0.35, 0.71 71.4 39.7
10. Exercise prescription 0.83 0.67, 0.96 93.7 62.5
11. Exercise preference 0.30 0.10, 0.50 63.5 47.9
12. Exercise adherence (n = 60) 0.54 0.36, 0.70 70.0 35.0
13. a. Benefits of weight loss 0.77 0.64, 0.90 84.1 30.4
b. Strategies for weight loss (n = 19) 0.60 0.20, 0.90 78.9 47.4
14. Walking aid 0.47 0.28, 0.66 66.7 37.5
15. Appliances and aids 0.41 0.23, 0.58 66.7 43.8
16. Work advice 0.41 0.17, 0.62 77.8 62.4
17. Footwear advice 0.60 0.41, 0.75 74.6 36.3
95% CI: 95% confidence interval
n number of participants
aThe complete quality indicator corresponding to each number can be found in Additional file 10 Table S1
Table 3 Agreement between treating physiotherapists and participants (n = 65) at Week 1 for individual quality indicator
Quality Indicators a Cohen’s Kappa 95% CI Observed agreement (%) Expected agreement (%)
1. Osteoarthritis assessment 0.09 −0.06-0.24 76.9 74.6
2. Comorbidities 0.17 −0.01-0.38 61.5 53.5
3. Depression screening 0.21 0.04–0.40 69.2 61.1
4. Depression referral 0.26 0–0.50 64.6 52.0
5. Management plan −0.01 −0.16-0.18 67.7 68.0
6. Physiotherapy review 0.10 −0.06-0.27 46.2 39.9
7. Osteoarthritis definition 0.36 0.12–0.59 73.8 59.0
8. Osteoarthritis pain 0.25 0.03–0.46 66.2 54.6
9. Treatment risk and benefits −0.04 −0.23-0.16 46.2 48.1
10. Exercise prescription 0.29 0.07–0.48 75.4 65.4
11. Exercise preference 0.09 −0.12-0.32 72.3 69.5
12. Exercise adherence (n = 54) 0.23 −0.02-0.45 59.3 47.2
13. a. Benefits of weight loss 0.30 0.13–0.46 52.3 32.1
b. Strategies for weight loss (n = 14) 0.59 0–1 85.7 65.7
14. Walking aid 0.37 0.17–0.55 61.5 39.1
15. Appliances and aids 0.18 −0.05-0.39 58.5 49.6
16. Work advice 0.05 −0.17-0.28 63.1 61.3
17. Footwear advice 0.41 0.17–0.61 70.8 50.7
95% CI: 95% confidence interval
n number of participants
aThe complete quality indicator corresponding to each number can be found in Additional file 10 Table S1
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Discussion
This study developed a patient-reported QI tool to
measure and benchmark physiotherapy care for people
with hip and/or knee OA. A clinimetric evaluation of
the QI tool was then performed to establish its reliability
and validity in assessing physiotherapy care for this pa-
tient group.
Test-retest reliability for each subscale and total score
of the QUIPA tool was acceptable (ICC of ≥0.70) al-
though in most cases, the lower bound of the CIs was
below 0.70, reflecting variability in the data and/or lim-
ited sample size. However, reliability for individual items
varied. The item on exercise prescription (item #10) was
the only QI that achieved ‘almost perfect’ agreement
while the item relating to discussing the benefits of
weight loss (item #13a) reached ‘substantial’ agreement.
The better reliability of these two items compared to
that of others suggests that it was easier for patients to
understand their intent and to recall whether or not
these aspects of physiotherapy care were provided.
Most of the other items (n = 13) achieved ‘moderate’
agreement with three attaining ‘fair’ agreement. Ten
achieved high observed agreement (> 70%) despite high
variability in their Kappa estimates (as indicated by CI).
This may be due to the statistical effect of a high or low
prevalence of a specific answer for those items. High or
low prevalence reduces Kappa estimates despite high ob-
served agreement [36, 37]. For example, for the QI re-
lated to OA assessment (item #1), despite the high
observed agreement (78%), the Kappa estimate (95% CI)
=0.38 (0.11, 0.62) is low due to high prevalence of ‘yes’
(53 out of 63) responses (leading to a high expected
agreement). If agreement is expected to be high by
chance, perhaps because most participants select the
same value for an item, then even if observed agreement
is high, Cohen’s Kappa will be low. Conversely, for the
QI related to OA pain (item #8), despite the observed
agreement (76%) being comparable to item #1, the
prevalence of ‘yes’ (34 out of 63) response resulted in a
higher Kappa estimate (95% CI) =0.54 (0.32, 0.72) (Add-
itional file 9). The three items with the lowest Kappa es-
timates were related to OA assessment, management
plan and exercise preference. Despite efforts to maximise
specificity, these items likely remained ambiguous and
could be interpreted differently across participants. An-
other potential reason for disagreement between test
and retest scores was related to poor recall as we ob-
served interchanges between “yes/no” and “don’t re-
member” response options within an individual at W12
and W13. We deliberately chose a 3-month window
when developing the QUIPA tool in order to capture
multi-session episodes of physiotherapy care. Thus, we
evaluated test-retest reliability of the tool at thirteen
weeks, the period of maximum recall, in order to
establish reliability in the ‘worst case’ scenario. Reliability
may be greater with shorter recall periods.
Overall, despite generally low Kappa values for single
items of the QUIPA tool, the test-retest Kappa estimates
and observed agreement were comparable [21] or only
slightly lower [30] than previous patient-reported QI
tools for OA care which have been rolled out and now
used in practice. However, it must be noted that these
studies used a recall time frame of 2 weeks for evaluat-
ing test-retest reliability despite the tools having a max-
imum recall period of 3 months [21, 30]. It is therefore
not known whether the reliability estimates they re-
ported would have been lower if they had used a three-
month recall as we did.
In terms of validity, the QUIPA tool has acceptable
construct validity with all three pre-defined hypotheses
confirmed (P < 0.05). These hypotheses were similar to
those used for assessment of construct validity in other
QI tools for OA care [21, 30], although the sample size
in our subgroups was smaller. While construct validity
was supported, our data indicate that the tool does not
have acceptable criterion validity as assessed via com-
parison of participants’ responses at W1 to responses
provided by the physiotherapists.
The subscale scores, total scores and most of the indi-
vidual items of the QUIPA tool achieved low agreement
between participants and physiotherapists. Although the
recall period for participants was shorter for validity test-
ing, it is possible that treating physiotherapists might
have delivered the care as described by the QIs, but par-
ticipants might not remember receiving the care or mis-
interpreted the care received. Despite the consumer
input to the development of the QI items, it appears that
some items were ambiguous and likely to be interpreted
differently, particularly from the perspective of a patient
or a clinician. For example, for the item relating to re-
view (item #6), a treating physiotherapist might suggest
the participant see a physiotherapist for their hip and/or
knee OA only when their symptoms flared up and would
select the ‘yes’ response to this QI. For the participants,
they might only select the ‘yes’ response if their treating
physiotherapist proposed a specific date for their next
physiotherapy review. It was also not clear for clinicians
as to which responses to select if the participant volun-
tarily offered information relating to certain QIs without
any promptings from their treating physiotherapist. Fi-
nally, for QIs that were not applicable to all participants
(e.g. benefits of weight loss, walking aid, appliances and
aids, work advice and depression referral), there were
large inconsistencies between participants and their
treating physiotherapists concerning whether the ‘no’ or
the ‘not overweight’ / ‘no such problems’ option was se-
lected. For the item relating to discussing the benefits of
weight loss (item #13a), perceptions of overweight/obese
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can also differ between the participant and their physio-
therapist. Overall, it appears difficult to generate items
that are unambiguous, interpreted in the same way by
different users and capture all variations in provision of
care.
Future directions
This study lays the groundwork for future refinement of
the QUIPA tool, a patient-reported QI for benchmarking
quality of physiotherapy care in hip and/or knee OA.
Further refinement and re-evaluation are required to im-
prove the validity of the QUIPA tool. Considerations for
future refinements include a patient recall period shorter
than 3 months, removal of ambiguous items, develop-
ment of more comprehensive instructions to patients
about what they should consider when answering the
items and reduction of response options.
Strengths and limitations
This study has several strengths. The QIs were generated
from an international physiotherapy consensus exercise
[28] that used high-quality clinical guidelines for hip and
knee OA [1, 29]. Other strengths include robust meth-
odology to develop QIs (e.g. defined scope and purpose
of the QIs, involvement of patients and physiotherapists,
formulation of specific and measurable QIs [16, 38]) and
good response rates to all surveys. In addition, no previ-
ous studies have comprehensively evaluated the validity
of patient-reported QIs by assessing agreement between
patients and their treating clinicians.
Despite achieving the recommended sample size for
clinimetric testing, there was limited variation in the
profiles of the participants. As such, we had few partici-
pants within subgroups such as those who were over-
weight, had problems with their walking, daily activities
or work due to OA and with depression. Given these
small sample sizes, and the aim of this work, we elected
not to adjust for patient characteristics. Doing so may
introduce bias and noise into our estimates of interest.
In addition, during the course of this study, we were
made aware of the use of pre-treatment ‘registration’
forms in some physiotherapy clinics, which may contain
questions relating to the QIs. If information is collected
via a form before a consultation rather than via a discus-
sion during a consultation, this may lead to difficulties
deciding how to answer the QUIPA items. Finally, des-
pite attempts to increase variability in the data, the ma-
jority of the participants and treating physiotherapists
chose ‘yes’ as their response options to the QIs.
Conclusion
In conclusion, this study developed the first patient-
reported QI tool specifically to evaluate physiotherapy
care for hip and/or knee OA. The QUIPA tool showed
acceptable test-retest reliability for subscales and total
score but inadequate reliability for individual items.
Construct validity was confirmed but criterion validity
for individual items, subscales and the total score was in-
adequate. Further research is needed to refine the
QUIPA tool to improve its clinimetric properties before
it can be used to accurately assess quality of physiother-
apy care for hip and/or knee OA.
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